Logo image of PSTV

PLUS THERAPEUTICS INC (PSTV) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PSTV - US72941H5090 - Common Stock

0.5983 USD
+0.04 (+6.69%)
Last: 11/26/2025, 4:02:35 PM
0.5983 USD
0 (0%)
After Hours: 11/26/2025, 4:02:35 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PSTV. PSTV was compared to 533 industry peers in the Biotechnology industry. While PSTV seems to be doing ok healthwise, there are quite some concerns on its profitability. PSTV is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PSTV has reported negative net income.
PSTV had a negative operating cash flow in the past year.
In the past 5 years PSTV always reported negative net income.
PSTV had a negative operating cash flow in each of the past 5 years.
PSTV Yearly Net Income VS EBIT VS OCF VS FCFPSTV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M -25M

1.2 Ratios

With a Return On Assets value of -110.19%, PSTV is not doing good in the industry: 77.30% of the companies in the same industry are doing better.
The Return On Equity of PSTV (-407.06%) is worse than 75.23% of its industry peers.
Industry RankSector Rank
ROA -110.19%
ROE -407.06%
ROIC N/A
ROA(3y)-132.52%
ROA(5y)-105.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSTV Yearly ROA, ROE, ROICPSTV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PSTV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSTV Yearly Profit, Operating, Gross MarginsPSTV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

4

2. Health

2.1 Basic Checks

PSTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
PSTV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for PSTV has been increased compared to 5 years ago.
The debt/assets ratio for PSTV is higher compared to a year ago.
PSTV Yearly Shares OutstandingPSTV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
PSTV Yearly Total Debt VS Total AssetsPSTV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

PSTV has an Altman-Z score of -36.70. This is a bad value and indicates that PSTV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -36.70, PSTV is doing worse than 91.18% of the companies in the same industry.
There is no outstanding debt for PSTV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -36.7
ROIC/WACCN/A
WACC8.32%
PSTV Yearly LT Debt VS Equity VS FCFPSTV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

PSTV has a Current Ratio of 1.29. This is a normal value and indicates that PSTV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.29, PSTV is doing worse than 83.68% of the companies in the same industry.
PSTV has a Quick Ratio of 1.29. This is a normal value and indicates that PSTV is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.29, PSTV is not doing good in the industry: 82.93% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
PSTV Yearly Current Assets VS Current LiabilitesPSTV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.54% over the past year.
Looking at the last year, PSTV shows a decrease in Revenue. The Revenue has decreased by -8.16% in the last year.
PSTV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.61% yearly.
EPS 1Y (TTM)32.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.19%
Revenue 1Y (TTM)-8.16%
Revenue growth 3YN/A
Revenue growth 5Y-3.61%
Sales Q2Q%-4.05%

3.2 Future

PSTV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.19% yearly.
Based on estimates for the next years, PSTV will show a very strong growth in Revenue. The Revenue will grow by 89.59% on average per year.
EPS Next Y94.36%
EPS Next 2Y39.33%
EPS Next 3Y24.96%
EPS Next 5Y16.19%
Revenue Next Year15.9%
Revenue Next 2Y8.23%
Revenue Next 3Y60.98%
Revenue Next 5Y89.59%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PSTV Yearly Revenue VS EstimatesPSTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
PSTV Yearly EPS VS EstimatesPSTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 -500K -1M -1.5M -2M -2.5M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PSTV. In the last year negative earnings were reported.
Also next year PSTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSTV Price Earnings VS Forward Price EarningsPSTV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSTV Per share dataPSTV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5

4.3 Compensation for Growth

PSTV's earnings are expected to grow with 24.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.33%
EPS Next 3Y24.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PSTV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLUS THERAPEUTICS INC

NASDAQ:PSTV (11/26/2025, 4:02:35 PM)

After market: 0.5983 0 (0%)

0.5983

+0.04 (+6.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners1.27%
Inst Owner Change985.8%
Ins Owners0.21%
Ins Owner Change68.59%
Market Cap82.22M
Revenue(TTM)5.26M
Net Income(TTM)-20.57M
Analysts82
Price Target7.91 (1222.08%)
Short Float %8.09%
Short Ratio0.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.85%
Min EPS beat(2)-96.08%
Max EPS beat(2)121.79%
EPS beat(4)2
Avg EPS beat(4)-166.61%
Min EPS beat(4)-695.44%
Max EPS beat(4)121.79%
EPS beat(8)5
Avg EPS beat(8)-72.35%
EPS beat(12)7
Avg EPS beat(12)-48.7%
EPS beat(16)9
Avg EPS beat(16)-36.66%
Revenue beat(2)0
Avg Revenue beat(2)-8.5%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)-8.31%
Revenue beat(4)1
Avg Revenue beat(4)-2.38%
Min Revenue beat(4)-30.01%
Max Revenue beat(4)37.49%
Revenue beat(8)2
Avg Revenue beat(8)-2.75%
Revenue beat(12)3
Avg Revenue beat(12)-1.57%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.26%
PT rev (3m)-12.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)85.71%
EPS NY rev (1m)0%
EPS NY rev (3m)84.81%
Revenue NQ rev (1m)17.02%
Revenue NQ rev (3m)9.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.64
P/FCF N/A
P/OCF N/A
P/B 16.27
P/tB 19.09
EV/EBITDA N/A
EPS(TTM)-1.7
EYN/A
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.04
BVpS0.04
TBVpS0.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -110.19%
ROE -407.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-132.52%
ROA(5y)-105.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.8%
Cap/Sales 1.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z -36.7
F-Score4
WACC8.32%
ROIC/WACCN/A
Cap/Depr(3y)67.77%
Cap/Depr(5y)74.15%
Cap/Sales(3y)82.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.19%
EPS Next Y94.36%
EPS Next 2Y39.33%
EPS Next 3Y24.96%
EPS Next 5Y16.19%
Revenue 1Y (TTM)-8.16%
Revenue growth 3YN/A
Revenue growth 5Y-3.61%
Sales Q2Q%-4.05%
Revenue Next Year15.9%
Revenue Next 2Y8.23%
Revenue Next 3Y60.98%
Revenue Next 5Y89.59%
EBIT growth 1Y8.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year20.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-21.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.56%
OCF growth 3YN/A
OCF growth 5YN/A

PLUS THERAPEUTICS INC / PSTV FAQ

What is the fundamental rating for PSTV stock?

ChartMill assigns a fundamental rating of 2 / 10 to PSTV.


What is the valuation status for PSTV stock?

ChartMill assigns a valuation rating of 1 / 10 to PLUS THERAPEUTICS INC (PSTV). This can be considered as Overvalued.


Can you provide the profitability details for PLUS THERAPEUTICS INC?

PLUS THERAPEUTICS INC (PSTV) has a profitability rating of 0 / 10.


What is the financial health of PLUS THERAPEUTICS INC (PSTV) stock?

The financial health rating of PLUS THERAPEUTICS INC (PSTV) is 4 / 10.


Is the dividend of PLUS THERAPEUTICS INC sustainable?

The dividend rating of PLUS THERAPEUTICS INC (PSTV) is 0 / 10 and the dividend payout ratio is 0%.